Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

NCT00964171 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Bergonié